Ранние и поздние легочные осложнения лучевой терапии лимфомы Ходжкина


https://doi.org/10.18093/0869-0189-2013-0-6-92-98

Полный текст:


Аннотация

Ранние и поздние легочные осложнения лучевой терапии лимфомы Ходжкина


Об авторах

А. А. Даниленко
ФГБУ "Медицинский радиологический научный центр" Минздрава России
Россия

к. м. н., старший научный сотрудник отделения лучевой и лекарственной терапии гемобластозов

249036, Калужская обл., Обнинск, ул. Королева, 4. Тел.: 8-909-250-02-22.



С. В. Шахтарина
ФГБУ "Медицинский радиологический научный центр" Минздрава России
Россия

д. м. н., ведущий научный сотрудник отделения лучевой и лекарственной терапии гемобластозов 

249036, Калужская обл., Обнинск, ул. Королева, 4. Тел.: (48439) 9-31-01.



Список литературы

1. Williams J.P., Johnston C.J., Finkelstein J.N. Treatment for radiation-induced pulmonary late effects: Spoiled for choice or looking in the wrong direction? Curr. Drug Targets 2010; 11 (11): 1386–1394.

2. Notter R.H., Finkelstein J.N., Holm B.A. Lung injury: mechanisms, pathophysiology, and therapy. New York: Taylor Fransis, 2005.

3. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nature Rev. Cancer. 2006; 6: 702–713.

4. Mikkelsen R.B., Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003; 22: 5734–5754.

5. Fleckenstein K., Zgonjanin L., Chen L. et al. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2007; 68: 196–204.

6. Ghafoori P., Marks L.B., Vujaskovic Z. et al. Radiationinduced lung injury: assessment, management, and prevention. Oncology 2008; 22 (1): 37–47.

7. Young B., Lowe J.S., Stevens A., Heath J.W. Wheather′s functional histology: a text and colour atlas. 5rd ed. London: Churchill Livingstone, 2006.

8. Rubin P., Shapiro D.L., Finklestein J.N. et al. The early release of surfactant following lung irradiation of alveolar type II cells. Int. J. Radiat. Oncol. Biol. Phys.1980; 6: 75–77.

9. Allavena C., Conroy T., Aletti P. et al. Late cardiopulmonary toxicity after treatment for Hodgkin′s disease. Br. J. Cancer 1992; 65: 908–912.

10. Torrisi J.M., Schwartz L.H., Gollub M.J. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 2011; 258 (1): 41–56.

11. Трахтенберг А.Х., Чиссов В.И. Клиническая онкопульмонология. М.: ГЭОТАР Медицина, 2000.

12. Marks L.B., Fan M., Clough R. et al. Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints. Int. J. Radiat. Biol. 2000; 76: 469–475.

13. Goethals I., Dierckx R., Meerleer G. et al. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J. Nucl. Med. 2003; 44 (9): 1531–1539.

14. Bria W.F., Kanarek D.J., Kazemi H. Prediction of postoperative pulmonary function following thoracic operations: value of ventilation-perfusion scanning. J. Thorac. Cardiovasc. Surg.1983; 86: 186–192.

15. Rubenstein J., Richter M., Moldofsky P. et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int. J. Radiat. Oncol. Biol. Phys.1988; 15: 83–87.

16. Choi N., Kanarek D., Grillo H. Effect of post-operative radiotherapy on changes in pulmonary function in patients with stage II and IIIa lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1990; 18: 95–99.

17. Curran W., Moldofsky P., Solin L. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int. J. Radiat. Oncol. Biol. Phys.1992; 24: 31–36.

18. Boersma L., Damen.E., de Boer R. et al. A new method to determine dose-effect relations for local lung function changes using correlated SPECT and CT data. Radiother. Oncol.1993; 29: 110–116.

19. Boersma L., Damen E., de Boer R.W. et al. Estimation of overall pulmonary function after irradiation using doseeffect relations for local functional injury. Radiother. Oncol. 1995; 36: 15–23.

20. Boersma L., Damen E., de Boer R.W. et al. Recovery of overall and local function loss 18 monthsafter irradiation for malignant lymphoma. J. Clin. Oncol.1996; 14: 1431–1441.

21. Theuws J., Kwa S., Wagenaar A. et al. Prediction of overall pulmonary function loss in relation to 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother. Oncol. 1998; 49: 233–243.

22. Robnett T.J., Machtay M., Vines E.P. et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int. J. Radiat. Oncol. Biol. Phys.2000; 48: 89–94.

23. Kim T.H., Cho K.H., Pyo H.R. et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimentional conformal radiation therapy for lung cancer. Radiology 2005; 235: 208–215.

24. Kong F.M., Haymann J.A., Griffith K.A. et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 1075–1086.

25. Hua C., Hoth K.A., Wu S. et al. Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2012; 78 (1): 43–149.

26. Fox A.M., Dosoretz A.P., Mauch P.M. et al. Predictive factors for radiation pneumonitis in Hodgkin is lymphoma patients receiving combined modality therapy. Int. J. Radiat. Oncol. Biol. Phys. 2012; 83 (1): 277–283.

27. Koh E.S., Sun A., Tran T.H. et al. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin′s lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 2006; 66 (1): 223–228.

28. Meadors M., Floyd J., Perry M.C. Pulmonary toxicity of chemotherapy. Semin. Oncol. 2006; 33: 98–105.

29. Байсоголов Г.Д., Афанасова Н.В., Шахтарина С.В. и др. Изменения в легких у больных лимфогранулематозом I–II клинической стадии после комбинированного лечения. Мед. радиол. 1985; 3: 18–22.

30. Hirsch A., Van der Els N., Straus D.J. et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin`s disease. J. Clin. Oncol. 1996; 14: 1297–1305.

31. Macann A., Bredenfeld H., Muller R.P. et al. Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin′s lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin′s Lymphoma Study Group. Int. J. Radiat. Oncol. Biol. Phys. 2008; 70 (1): 161–165.

32. Бардычев М.С., Цыб А.Ф. Местные лучевые повреждения. М.: Медицина, 1985.

33. Park K.J., Chung J.Y., Chun M.S. et al. Radiation-induced lung disease and the impact of radiation methods on imaging features. Radiographics 2000; 20 (1): 83–98.

34. Abratt R., Morgan G. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002; 35: 103–109.

35. Rubin P., Finkelstein J., Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 1992; 24: 93–101.

36. Коврыжкина Т.А., Ильин Н.В., Акимов А.А. и др. Использование линейно-квадратичной модели для оценки поздних лучевых повреждений легких у больных лимфогранулематозом. Мед. радиол. 1997; 3: 59–63.

37. Villani F., Busia A., Villani M. et al. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin′s disease. Anticancer Res. 2009; 29 (2): 777–784.

38. Lund M.B., Kongerud J., Boe J. et al. Late complications after treatment of Hodgkin`s disease. Tidsskr. Norske Laegeforen. 1999; 119 (7): 933–937.

39. Enrichi R.M., Anselmo A.P., Donato V. et al. Relapse and late complications in early-stage Hodgkin′s disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD. Haematologica 1999; 84 (10): 17–23.

40. Brusamolino E., Baio A., Orlandi E. et al. Long-term events in adult patients with clinical stage IA–IIA nonbulky Hodgkin`s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin. Cancer Res. 2006; 12 (21): 6487–6493.

41. Andrieu J.M., Jais J.P., Colonna P. et al. Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin′s disease at advanced stages. Ann. Oncol. 1998; 9 (2): 195–203.

42. Даниленко А.А., Шахтарина С.В., Афанасова Н.В., Павлов В.В. Изменения в легких у больных лимфомой Ходжкина после химиотерапии по схемам СОРР, ABVD, BEACOPP и облучения средостения в суммарной очаговой дозе 20–30 Гр. Клин. онкогематол. 2010; 3 (4): 354–358.

43. Sasse A.D., Clark L.G., Sasse E.C., Clark O.A. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64: 784–791.

44. Levi M., Knol J.A., Ensminger W.D. et al. Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys. Drug Metabol. Disposit. 2002; 30: 1425–1430.

45. Greenberg J.S., Epperly M.W. Antioxidant gene therapeutic approaches to normal tissue protection and tumor radiosensitization. In Vitro 2007; 21: 141–146.

46. Gauter7Fleckenstein B., Fleckenstein K., Owzar K. et al. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic. Biol. Med. 2008; 44: 982–989.

47. Williams J.P., Hernady E., Johnston C.J. et al. Effect of administration of lovastatin on the development of late pulmonary effects following whole lung irradiation in a murine model. Radiat. Res. 2004; 161: 560–567.

48. Xie C.H., Zhang M.S., Zhou Y.F. et al. Chinese medicine Angelica sinensis supresses radiation-induced expression of TNF-α and TGF-β in mice. Oncol. Rep. 2006; 15: 1429–1436.

49. Kozaka Y., Mitsumori M., Araki N. et al. Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast. Int. J. Clin. Oncol. 2006; 11: 482–486.


Дополнительные файлы

Для цитирования: Даниленко А.А., Шахтарина С.В. Ранние и поздние легочные осложнения лучевой терапии лимфомы Ходжкина.  Пульмонология. 2013;(6):92-98. https://doi.org/10.18093/0869-0189-2013-0-6-92-98

For citation: Danilenko A.A., Shakhtarina S.V. Early and long-term pulmonary complications of radiotherapy of Hodgkin's lymphoma. Russian Pulmonology. 2013;(6):92-98. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-6-92-98

Просмотров: 286

Обратные ссылки

  • Обратные ссылки не определены.


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)